Used as a key intermediate in the synthesis of biologically active compounds, particularly in the development of pharmaceuticals targeting central nervous system disorders. Its unique cyclopropane scaffold with fluorinated substituents enhances metabolic stability and membrane permeability, making it valuable in medicinal chemistry. The compound's stereochemistry supports high selectivity in receptor binding, which is critical for drugs requiring precise molecular interactions. It is also employed in the preparation of enzyme inhibitors, where the difluoromethyl group acts as a bioisostere, improving pharmacokinetic properties.